MedDataX Logo

Project COPE-Spain (Coping Options for Parent Empowerment)

NCT07006220 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-08-22

No results posted yet for this study

Summary

The goal of this study trial is to establish the preliminary clinical utility of the COPE program (Coping Options for Parent Empowerment) adapted for caregivers of adolescents in the Spanish context. This program aims to improve parents' emotional well-being, enhance their parenting skills, and promote positive changes in their childrens' emotional and behavioral well-being. This study will adapt the COPE program for in-person group administration in the Spanish context, specifically in the school setting.

Conditions

  • Anxiety Symptoms
  • Depressive Symptoms
  • Parental Stress

Interventions

BEHAVIORAL

COPE Program

The COPE Program (Coping Options for Parent Empowerment) is a brief, structured, transdiagnostic intervention designed to enhance parents' emotional regulation skills, improve parenting strategies, and foster a positive family environment. The program consists of four in-person group sessions, each lasting 90 minutes, conducted over four consecutive weeks. Each session focuses on specific emotional regulation and parenting skills: Session 1: Understanding emotional responses and parenting strategies based on positive reinforcement, selective attention, and empathy. Session 2: Identifying family values, promoting healthy routines, and planning alternative parenting behaviors. Session 3: Practicing mindfulness techniques and modeling emotional regulation in the presence of children. Session 4: Addressing intolerance to uncertainty, cognitive distortions, and promoting healthy independence in adolescents.

Sponsors & Collaborators

  • IES Isaac Newton

    collaborator UNKNOWN

  • Universidad Nacional de Educación a Distancia

    lead OTHER

Principal Investigators

  • Julia Garcia-Escalera, Associate Professor · Universidad Nacional de Educación a Distancia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-22
Primary Completion
2025-07-31
Completion
2025-12-01

Countries

  • Spain

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07006220 on ClinicalTrials.gov